January 20, 2016
In his State of the Union address President Barack Obama made finding a cure for cancer a moonshot of his final year in office. It's a lofty goal as cancer is not just one disease but many. But with the help of doctors at a New York institute one woman may have found her cure, tailored just for her. NY1's Erin Billups filed the following report.Irene Price was diagnosed with bladder cancer in 2008. She was treated, it went away but then it came back in 2013. She had surgery to remove her bladder and underwent chemotherapy. A short time later it reappeared in her liver."I responded to...
November 30, 2015
Congratulations to Dr. Ethel Cesarman on receiving a two-year $996,000 Starr Cancer Consortium grant!
Along with her collaborators Dr. Ari Melnick at WCMC and Drs. Robert Roeder and David Allis at Rockefeller University, Dr. Cesarman will be studying the role of linker histone H1 mutations in lymphoma pathogenesis.
Ethel Cesarman, MD, PhDProfessor of Pathology and Laboratory Medicine
November 13, 2015
Precision Medicine team at Weill Cornell Medicine and NewYork-Presbyterian will introduce whole exome sequencing test, EXaCT-1, to clinical setting
October 21, 2015
The department is pleased to announce the appointment of Brian Robinson, MD to Chief of Surgical Pathology. In this role, Dr. Robinson will be responsible for day-to-day operations of Surgical Pathology and will report directly to Dr. Alain Borczuk.
Brian Robinson, MDChief, Surgical Pathology
After graduating from Weill Cornell Medical College, Brian joined our residency training program in anatomic pathology. After completing our program in stellar fashion, he completed a fellowship in urologic pathology at the Johns Hopkins Hospital. We recruited Brian back to our department in July 2010.
September 16, 2015
The Bone Marrow Pathology Group recently held their annual meeting in New York, NY on September 11, 2015, hosted by Dr. Attilio Orazi.
August 6, 2015
An article has been published in Nature Communications...
(L to R) Michael Kluk, MD, PhD;Teresa Sanchez, PhD
http://www.nature.com/ncomms/2015/150805/ncomms8893/full/ncomms8893.html
June 2, 2015
Congratulations to Dr. Domenick J. Falcone who has received two teaching awards during Convocation on May 27, 2015!Charles L. Bardes, MD Teaching Prize (2015)The prize was established in 2000 by David and Betty Cooper-Wallerstein, in gratitude for the excellent and compassionate medical care provided by Dr. Bardes to three generations of Cooper-Wallerstein family. The prize is awarded annually to a member of the faculty, who has been an outstanding teacher at Weill Cornell Medical College, demonstrated leadership, dedication, and concern for the students. The recipient is selected by a...
June 1, 2015
An international collaboration of researchers are advancing precision medicine to men with a common and aggressive form of prostate cancer.
May 8, 2015
The medication was so effective in mantle cell lymphoma, an aggressive, incurable cancer, that the Food and Drug Administration named ibrutinib a "breakthrough" drug. The unprecedented response — 68 percent of patients went into partial or complete remission when they took it — gained the agent accelerated approval last November.But the disease remains a challenge. Researchers, including those at Weill Cornell Medical College who participated in the ibrutinib clinical trial, found that lymphoma cells in the majority of patients who were taking the drug on its own became resistant to it,...
April 21, 2015
Weill Cornell Medical College investigators, led by Drs. Mark A. Rubin, Sandra J. Shin and Juan Miguel Mosquera, tried to validate a previously reported molecular finding on triple negative breast cancer that many hoped would lead to targeted treatments for the aggressive disease. Instead, they discovered that the findings were limited to a single patient and could not be applied to further clinical work.